Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapies for breast cancer.

The Journal of clinical investigation - 1 Oct 2011

Higgins Michaela J, Baselga José

Abstract excerpt

In recent years the description of well-defined molecular subtypes of breast cancer, together with the identification of the driving genetic alterations and signaling pathways, has led to the clinical development of a number of successful molecular targeted agents. This is best exemplified in the subset of HER2-amplified breast cancers, in which an increasing number of active agents are changing the natural...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Clinical Trials as Topic
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Hormone-Dependent

Share to Phosphatidylinositol 3-Kinases

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Open in PubMed Open full text

Identifiers

PMID: 21965336
DOI: 10.1172/JCI57152
PMCID: PMC3195649

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapies for breast cancer.PMID 21965336Read ↗

[Novel target therapies used in breast cancer management].Semantic proximity Read ↗

Targeted therapy for breast cancer.Semantic proximity Read ↗

Targeted Therapies for Triple-Negative Breast Cancer.Semantic proximity Read ↗

Targeted and cytotoxic inhibitors used in the treatment of breast cancerSemantic proximity Read ↗

Divide and Conquer—Targeted Therapy for Triple-Negative Breast CancerSemantic proximity Read ↗

Advances in systemic therapy for metastatic breast cancer: future perspectives.Semantic proximity Read ↗

Molecular targets as therapeutic strategies in the management of breast cancer.Semantic proximity Read ↗

Identifying Breast Cancer Druggable Oncogenic Alterations: Lessons Learned and Future Targeted OptionsSemantic proximity Read ↗

New drugs for breast cancer subtypes: Targeting driver pathways to overcome resistanceSemantic proximity Read ↗

Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity Read ↗

Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designsSemantic proximity Read ↗

Targeting basal-like breast cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.